These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 9159562)
1. Pharmacokinetic and pharmacodynamic interaction trial after repeated oral doses of imidapril and digoxin in healthy volunteers. Harder S; Thürmann PA Br J Clin Pharmacol; 1997 May; 43(5):475-80. PubMed ID: 9159562 [TBL] [Abstract][Full Text] [Related]
2. Single dose and steady state pharmacokinetics and pharmacodynamics of the ACE-inhibitor imidapril in hypertensive patients. Harder S; Thürmann PA; Ungethüm W Br J Clin Pharmacol; 1998 Apr; 45(4):377-80. PubMed ID: 9578185 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic and dynamic interactions of the angiotensin-converting enzyme inhibitor imidapril with hydrochlorothiazide, bisoprolol and nilvadipine. Breithaupt-Grögler K; Ungethüm W; Meurer-Witt B; Belz GG Eur J Clin Pharmacol; 2001 Jul; 57(4):275-84. PubMed ID: 11549204 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of imidapril and its active metabolite imidaprilat following single dose and during steady state in patients with impaired liver function. Hoogkamer JF; Kleinbloesem CH; Nokhodian A; Ouwerkerk MJ; Lankhaar G; Ungethüm W; Kirch W Eur J Clin Pharmacol; 1997; 51(6):489-91. PubMed ID: 9112065 [TBL] [Abstract][Full Text] [Related]
5. Protection of the cardiovascular system by imidapril, a versatile angiotensin-converting enzyme inhibitor. Hosoya K; Ishimitsu T Cardiovasc Drug Rev; 2002; 20(2):93-110. PubMed ID: 12177688 [TBL] [Abstract][Full Text] [Related]
6. A saturable tissue-angiotensin I converting enzyme (ACE) binding model for the pharmacokinetic analysis of imidapril, a new ACE inhibitor, and its active metabolite in human. Tagawa K; Mizobe M; Noda K Biol Pharm Bull; 1995 Jan; 18(1):64-9. PubMed ID: 7735253 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic and pharmacodynamic study of imidaprilat, an active metabolite of imidapril, a new angiotensin-converting enzyme inhibitor, in spontaneously hypertensive rats. Yamanaka K; Takehara N; Murata K; Banno K; Sato T J Pharm Biomed Anal; 1997 Aug; 15(12):1851-9. PubMed ID: 9278890 [TBL] [Abstract][Full Text] [Related]
8. Radioimmunoassay for imidapril, a new angiotensin-converting enzyme inhibitor, and imidaprilat, its active metabolite, in human plasma and urine. Yamanaka K; Morikawa S; Murata K; Banno K; Sato T; Takai T; Suzuki T; Mizobe M; Ito M; Ishibashi K J Pharm Biomed Anal; 1996 Jan; 14(3):281-7. PubMed ID: 8851752 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of imidapril and its active metabolite imidaprilat following single dose and during steady state in patients with chronic renal failure. Hoogkamer JF; Kleinbloesem CH; Nokhodian A; Ouwerkerk MJ; Lankhaar G; Ungethüm W; Kirch W Eur J Clin Pharmacol; 1998 Mar; 54(1):59-61. PubMed ID: 9591932 [TBL] [Abstract][Full Text] [Related]
10. Steady-state pharmacokinetics and pharmacodynamics of imidaprilat, an active metabolite of imidapril, a new angiotensin-converting enzyme inhibitor in spontaneously hypertensive rats. Yamanaka K; Takehara N; Murata K; Banno K; Sato T J Pharm Sci; 1996 Nov; 85(11):1234-7. PubMed ID: 8923331 [TBL] [Abstract][Full Text] [Related]
11. High- versus low-dose ACE inhibition in chronic heart failure: a double-blind, placebo-controlled study of imidapril. van Veldhuisen DJ; Genth-Zotz S; Brouwer J; Boomsma F; Netzer T; Man In 'T Veld AJ; Pinto YM; Lie KI; Crijns HJ J Am Coll Cardiol; 1998 Dec; 32(7):1811-8. PubMed ID: 9857856 [TBL] [Abstract][Full Text] [Related]
12. Lack of effect of eprosartan on the single dose pharmacokinetics of orally administered digoxin in healthy male volunteers. Martin DE; Tompson D; Boike SC; Tenero D; Ilson B; Citerone D; Jorkasky DK Br J Clin Pharmacol; 1997 Jun; 43(6):661-4. PubMed ID: 9205830 [TBL] [Abstract][Full Text] [Related]
13. Effect of multiple doses of losartan on the pharmacokinetics of single doses of digoxin in healthy volunteers. De Smet M; Schoors DF; De Meyer G; Verbesselt R; Goldberg MR; Fitzpatrick V; Somers G Br J Clin Pharmacol; 1995 Dec; 40(6):571-5. PubMed ID: 8703664 [TBL] [Abstract][Full Text] [Related]
14. No pharmacokinetic or pharmacodynamic interaction between digoxin and the oral direct thrombin inhibitor ximelagatran in healthy volunteers. Sarich TC; Schützer KM; Wollbratt M; Wall U; Kessler E; Eriksson UG J Clin Pharmacol; 2004 Aug; 44(8):935-41. PubMed ID: 15286098 [TBL] [Abstract][Full Text] [Related]
15. Determination of imidapril and imidaprilat in human plasma by high-performance liquid chromatography-electrospray ionization tandem mass spectrometry. Mabuchi M; Kano Y; Fukuyama T; Kondo T J Chromatogr B Biomed Sci Appl; 1999 Oct; 734(1):145-53. PubMed ID: 10574200 [TBL] [Abstract][Full Text] [Related]
16. Moexipril shows a long duration of action related to an extended pharmacokinetic half-life and prolonged ACE inhibition. Cawello W; Boekens H; Waitzinger J; Miller U Int J Clin Pharmacol Ther; 2002 Jan; 40(1):9-17. PubMed ID: 11837383 [TBL] [Abstract][Full Text] [Related]
17. Systemic, regional and cerebral hemodynamic effects of a new angiotensin converting enzyme inhibitor, imidapril, in healthy volunteers. Démolis P; Annane D; Duhazé P; Giudicelli JF Fundam Clin Pharmacol; 1994; 8(1):80-9. PubMed ID: 8181800 [TBL] [Abstract][Full Text] [Related]
18. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 6th communication: interspecies comparison of pharmacokinetics and excretion of imidapril metabolites in rats, dogs, and monkeys. Yamada Y; Endo M; Kohno M; Otsuka M; Takaiti O Arzneimittelforschung; 1992 Apr; 42(4):499-506. PubMed ID: 1642673 [TBL] [Abstract][Full Text] [Related]